Clinical Trial Update: Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use [NA]

View source ↗

Summary

This planned trial evaluates whether a probiotic containing Bifidobacterium breve PRL2020 given as oral drops can prevent antibiotic-associated side effects fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
• Bifidobacterium breve PRL2020 probiotic oral drops (Bifidobacterium breve PRL2020)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Antibiotic-associated Diarrhea | NA | Status: NOT_YET_RECRUITING